Concepedia

Lingfan Xu

LX

23

Publications

968

Citations

16

H-Index

2014

Active since

Affiliations

First Affiliated Hospital of Anhui Medical University(Current)

Anhui Medical University

Duke University

Second Military Medical University

Changhai Hospital

Lingfan Xu is an author at First Affiliated Hospital of Anhui Medical University specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2014–2024

23

Publications

23

Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

Su Deng, Choushi Wang, Yunguan Wang et al. · Nature Cancer · 2022 · 138 citations · Full text

, , +18

Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

Yanjing Li, Yiping He, William Butler et al. · Science Translational Medicine · 2019 · 135 citations · Full text

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway

Yu Yin, Lingfan Xu, Yan Chang et al. · Molecular Cancer · 2019 · 120 citations · Full text

A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer

Lingfan Xu, Yu Yin, Yanjing Li et al. · Proceedings of the National Academy of Sciences · 2021 · 68 citations · Full text

Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell

Junyi Chen, Fubo Wang, Huan Xu et al. · Frontiers in Oncology · 2020 · 65 citations · Full text

Rows per page

1–5 of 23